NP / PA
Foley, Jenna
Foley, Jenna was paid $366K by Medicaid between Jan 2018 and May 2023, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoFOLEY, JENNA
CAMBRIDGE, MA 02138
CAMBRIDGE, MA 02138
33aNPI1053651562assigned 02/20/2013
33bProvider typeFamily Nurse Practitioner
28Total paid$366K
24GClaims7,814
24DCodes billed23
24AFirst – last monthJan 2018 – May 2023
Compared with peers
Next to other Family Nurse Practitioner providers in Massachusetts
Rank by total paid#9 of 327
Median peer was paid$5K
This provider vs. median68×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,477 | $56K | |
| 2019 | 620 | $36K | |
| 2020 | 466 | $19K | |
| 2021 | 1,570 | $84K | |
| 2022 | 2,846 | $135K | |
| 2023 | 835 | $36K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 3,873 | 3,751 | $184K |
| 87428 | 10% | 650 | 639 | $37K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8.6% | 321 | 271 | $31K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.2% | 306 | 256 | $30K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7.8% | 363 | 321 | $29K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5.4% | 272 | 241 | $20K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 707 | 695 | $7K |
| 87481 | 1.5% | 24 | 24 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.3% | 37 | 37 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.3% | 75 | 70 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 68 | 67 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 219 | 215 | $3K |
11 more codes
| 81025 | <1% | 294 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 32 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 44 | $742.19 |
| 81002 | <1% | 365 | $738.99 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 15 | $620.70 |
| 87480 | <1% | 14 | $560.62 | |
| 87660 | <1% | 14 | $493.35 | |
| 87088 | <1% | 25 | $491.01 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 44 | $375.40 |
| 87070 | <1% | 14 | $297.58 | |
| 81001 | <1% | 38 | $276.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.